Biotechnology - , ,
The (U)ltrasound-based (W)ashington (M)olecular (I)maging and (T)herapy center, or UWAMIT, focuses on the discovery, development, translation, and commercialization of molecular imaging and therapy technologies. UWAMIT is strategically focused on bridging the so called "Valley of Death"- where good ideas by university investigators are lost from evolving into real commercial solutions for improved Healthcare. UWAMIT bridges this gap by focusing on the clinical outcomes and specific clinical constraints that develop into healthcare opportunities. UWAMIT aligns the clinical market opportunity with internal research objectives to connect opportunity with innovation. UWAMIT is strategically positioned to develop new companies and partner with existing companies to pursue market opportunities in molecular imaging and therapy. UWAMIT is strategically positioned to: 1. Focus on clinical outcomes and specific clinical constraints that develop into healthcare opportunities. 2. Align clinical market opportunities with internal research objectives connecting opportunity with innovation. 3. Develop new companies and license existing technology. 4. Partner with existing companies to pursue market opportunities. UWAMIT aims to improve health and healthcare throughout Washington State and create jobs through: 1. Funding and developing new spinout companies. 2. Corporate Partnerships 3. Funding innovative healthcare research